Surgical Treatment and Outcomes of Colorectal Cancer Patients During the COVID-19 Pandemic: A National Population-based Study in England

Objective: To compare the management and outcomes of colorectal cancer (CRC) patients during the first 2 months of the COVID-19 pandemic with the preceding 6 months. Background: The pandemic has affected the diagnosis and treatment of CRC patients worldwide. Little is known about the safety of major resection and whether creating “cold” sites (COVID-free hospitals) is effective. Methods: A national study in England used administrative hospital data for 14,930 CRC patients undergoing surgery between October 1, 2019, and May 31, 2020. Mortality of CRC resection was compared before and after March 23, 2020 (“lockdown” start). Results: The number of elective CRC procedures dropped sharply during the pandemic (from average 386 to 214 per week), whereas emergency procedures were hardly affected (from 88 to 84 per week). There was little change in characteristics of surgical patients during the pandemic. Laparoscopic surgery decreased from 62.5% to 35.9% for elective and from 17.7% to 9.7% for emergency resections. Surgical mortality increased slightly (from 0.9% to 1.2%, P = 0.06) after elective and markedly (from 5.6% to 8.9%, P = 0.003) after emergency resections. The observed increase in mortality during the first phase of the pandemic was similar in “cold” and “hot” sites (P > 0.5 elective and emergency procedures). Conclusions: The pandemic resulted in a 50% reduction in elective CRC procedures during the initial surge and a substantial increase in mortality after emergency resection. There was no evidence that surgery in COVID-free “cold” sites led to better outcomes in the first 2 months. Mini-abstract: Elective surgery for colorectal cancer dropped by 50% at the start of the COVID-19 pandemic in England. Mortality after major resection increased from 0.9% to 1.2% for elective and from 5.6% to 8.9% for emergency procedures. There was no evidence that using COVID-free hospitals improved outcomes during the initial surge.

[1]  P. Dhar,et al.  IMPACT OF COVID-19 ON CANCER CARE , 2021, GLOBAL JOURNAL FOR RESEARCH ANALYSIS.

[2]  H. A. Blake,et al.  The impact of the first peak of the COVID‐19 pandemic on colorectal cancer services in England and Wales: A national survey , 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[3]  Colin Simpson,et al.  Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People , 2021, SSRN Electronic Journal.

[4]  A. Charlett,et al.  Epidemiological and clinical characteristics of early COVID-19 cases, United Kingdom of Great Britain and Northern Ireland , 2020, Bulletin of the World Health Organization.

[5]  A. Haynes,et al.  Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  W. King,et al.  Mortality due to cancer treatment delay: systematic review and meta-analysis , 2020, BMJ.

[7]  J. Rohn,et al.  A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site , 2020, International Journal of Surgery.

[8]  N. Ahuja,et al.  Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic , 2020, Annals of surgery.

[9]  Gary Alan Bass,et al.  Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Baker,et al.  A single-centre observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: Is there a “lockdown” effect? , 2020, International Journal of Surgery.

[11]  Shaun T. Griffin.  Covid-19: Waiting times in England reach record highs , 2020, BMJ.

[12]  J. Huddy,et al.  Continuation of minimally invasive surgery in the COVID-19 pandemic , 2020, Techniques in Coloproctology.

[13]  J. Huddy,et al.  Establishing a “cold” elective unit for robotic colorectal and urological cancer surgery and regional vascular surgery following the initial COVID-19 surge , 2020, The British journal of surgery.

[14]  G. Pellino,et al.  The COVID‐19 pandemic: considerations for resuming normal colorectal services , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[15]  D. Chan,et al.  Maintaining quality of care in colorectal cancer surgery during the COVID-19 pandemic , 2020, The British journal of surgery.

[16]  M. Carvello,et al.  With adequate precautions colorectal cancer surgery can be safely continued during COVID‐19 pandemic , 2020, The British journal of surgery.

[17]  A. Purushotham,et al.  The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study , 2020, The Lancet Oncology.

[18]  Tushar Aggarwal,et al.  Implementation of a clinical pathway for the surgical treatment of colorectal cancer during the COVID‐19 pandemic , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  K. Bhaskaran,et al.  Factors associated with COVID-19-related death using OpenSAFELY , 2020, Nature.

[20]  COVIDSurg Collaborative.  Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study , 2020 .

[21]  A. Mirnezami,et al.  The impact of COVID‐19 on advanced colorectal cancer , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  A. Güemes,et al.  Impact of Personal Protective Equipment on Surgical Performance During the COVID-19 Pandemic , 2020, World Journal of Surgery.

[23]  H. Fillmann,et al.  Potential impact of COVID-19 on colorectal disease management , 2020, Journal of Coloproctology.

[24]  B. Ebert,et al.  The impact of the COVID-19 pandemic on cancer care , 2020, Nature Cancer.

[25]  A. Ejaz,et al.  Cancer Surgery During COVID-19 , 2020, Annals of surgery.

[26]  J. Balibrea,et al.  Reduction in emergency surgery activity during COVID-19 pandemic in three Spanish hospitals , 2020, The British journal of surgery.

[27]  Gary Alan Bass,et al.  Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans , 2020, The British journal of surgery.

[28]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[29]  G. Barlow,et al.  Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission , 2020, Journal of Infection.

[30]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[31]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[32]  Pia Hardelid,et al.  Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC) , 2017, International journal of epidemiology.

[33]  K. Puxty,et al.  Critical care provision after colorectal cancer surgery , 2016, BMC Anesthesiology.

[34]  J. van der Meulen,et al.  Identifying co‐morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score , 2010, The British journal of surgery.

[35]  Data Manual.  The National Bowel Cancer Audit , 2009 .